02
February

10:00 AM EST

IQVIA Patient Recruitment and Enablement Boardroom: Turning Insights to Patient-Centered Actions: Building the Expected Personalized Trial Experience

Virtual Boardroom

What to expect

Timely information, interactive format

Today’s clinical research has adopted consumer-driven tactics to help expand the traditional site boundary and improve trial participation and engagement. With help from real world insights, technologies and solutions that operationalize recruitment and enablement goals, clinical trials can now be more accessible and representative of the population, which is a critical requirement to evaluating the efficacy of novel therapeutics.

Online Agenda

Why you should attend

We invite you to contribute your expertise to an exclusive boardroom discussion about clinical trial payments.

Meet Our Facilitator

Ann Dokus

Senior Director, Experience Optimization Patient Centric Solutions and Decentralized Trials IQVIA

<p>Ann Dokus is the Senior Director of Experience Optimization in the Patient and Site Centric Solutions organization. An industry veteran of with over 30 years experience in Pharmaceutical R&D, Medical Devices, Information Technology and Clinical Research, Ann’s journey has spanned start ups, Fortune 100 companies and ultimately a role at IQVIA.</p>
<p>Ann is a passionate advocate for Patients, firmly believing in delivering clinical research opportunities to the community. She has spearheaded technology initiatives in Identity and Access Management, Clinical Trial Matching, Patient Recruitment, Medical Records Retrieval and is now excited about the power of Artificial Intelligence to deliver accessibility to trials. A firm believer in meeting the patients where they are, Ann’s focus at IQVIA is supporting sponsors and sites in delivering the promise of the “last mile” … enrolled, supported and sustained patient engagement while optimizing the patient experience throughout the journey.</p>

Katie Shaw

Senior Director Global Patient & Site Solutions IQVIA

More about IQVIA

More information

IQVIA is a leading global provider of advanced analytics, technology solutions, and clinical research services to the life sciences industry. IQVIA creates intelligent connections to deliver powerful insights with speed and agility—enabling customers to accelerate the clinical development and commercialization of innovative medical treatments that improve healthcare outcomes for patients. With approximately 82,000 employees, IQVIA conducts operations in more than 100 countries. You can learn more: iqvia.com

Further Information

Interested in attending this virtual roundtable or running your own? Drop us a message today and we will get in touch

Here To Help

Need help registering your team? Just get in touch and a member of the team will be happy to help.

Europe

USA East

USA West

Webinars

Dinners & Spotlights

R&D

Clinical Trials IQVIA

IQVIA Virtual Boardroom – 26th April 2022

IQVIA Patient Recruitment and Enablement Boardroom: Turning Insights to Patient-Centered Actions: Building the Expected Personalized Trial Experience

Virtual Boardroom

Timely information, interactive format

Online Agenda

Discuss how consumer-influenced trial designs incorporate patient voice to identify trial expectations and remove burden.

Explore key patient engagement approaches within the industry and define accessibility goals reflective of the community impacted that engage diverse and underserved populations.

Define a future process to achieve a new level of patient engagement without compromise so you can focus on developing life-changing therapies faster for those who need them most.

Why you should attend

Meet Our Facilitator

Ann Dokus

Katie Shaw

More about IQVIA

Further Information

Here To Help

Select days you wish to attend You can add multiple days

VAT Excluded

Select days you wish to attend You can add multiple days

Pass includes:

VAT Excluded

About You

Your Address

About Your Company

This is required field*

Bone/Osteoporosis

Immunology

Orthopaedics

Cardiovascular

Infectious diseases

Pulmonology

CNS

Inflammation

Psychiatry

Dermatology

Internal diseases

Respiratory

Diabetes

Metabolic diseases

Rheumatology

Endocrinology

Nephrology

Surgery

ENT

Neurology

Urology

Gastroenterology

Oncology

Vaccines

Haematology

Ophthalmology

Thrombosis

Rare Diseases

This is required field*

0-10

10-50

50-100

100-500

500+

This is required field*

This is required field*

Under £100,000

£100,000 - £500,000

£500,000 - £1,000,000

£1,000,000 - £5,000,000

£5,000,000 - £10,000,000

£10,000,000 +

This is required field*

This is required field*

Discovery to Development

Pre-Clinical

Phase 1

Phase 2

Phase 3